Rigel Pharmaceuticals, Inc. (RIGL) Social Stream
RIGEL PHARMACEUTICALS INC (RIGL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RIGL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 4 | $11 | $7 | $8.5 | $1.12 | 658.93% |
| 2022-03-02 | 4 | $11 | $7 | $8.25 | $1.12 | 636.61% |
| 2022-05-03 | 5 | $11 | $4 | $7.4 | $1.12 | 560.71% |
| 2022-05-05 | 5 | $11 | $4 | $7.2 | $1.12 | 542.86% |
| 2022-06-09 | 7 | $7 | $0.8 | $2.008 | $1.12 | 79.29% |
| 2022-07-25 | 7 | $7 | $0.8 | $2.15 | $1.12 | 91.96% |
| 2022-08-03 | 7 | $7 | $0.8 | $2.221 | $1.12 | 98.3% |
| 2022-10-11 | 7 | $15 | $0.8 | $3.678 | $1.12 | 228.39% |
| 2022-11-06 | 7 | $15 | $0.8 | $3.535 | $1.12 | 215.62% |
| 2022-12-02 | 7 | $15 | $0.8 | $3.478 | $1.12 | 210.54% |
| 2023-03-08 | 7 | $15 | $0.8 | $3.492 | $1.12 | 211.79% |
| 2023-03-09 | 7 | $15 | $1.2 | $3.992 | $1.12 | 256.43% |
| 2023-05-03 | 7 | $15 | $1.2 | $3.993 | $1.12 | 256.52% |
| 2023-08-02 | 6 | $15 | $1.3 | $4.175 | $1.12 | 272.77% |
The Trend in the Analyst Price Target
Over the past 39 months, RIGL's average price target has gone down $2.84.
RIGL reports an average of 238.01% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-11 | 7 | 15 | 0.8 | 3.492 | 1.53 | 128.24% |
| 2023-03-09 | 7 | 15 | 1.2 | 4.325 | 1.68 | 157.44% |
| 2023-03-09 | 6 | 15 | 1.2 | 3.992 | 1.68 | 137.62% |
| 2023-07-24 | 6 | 15 | 1.2 | 4.158 | 1.27 | 227.4% |
| 2023-08-02 | 6 | 15 | 1.3 | 4.175 | 1.29 | 223.64% |
RIGL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 2 | 0 | 4 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 153 days, RIGL's average broker recommendation rating worsened by 0.19.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how RIGEL PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is higher than 79.77% of that group.
- RIGL has a lower variance in analysts' estimates than -1698.72% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, RIGEL PHARMACEUTICALS INC's number of analysts covering the stock is higher than 1415% of them.
- In the context of stocks in the small market cap category, RIGEL PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1374.91% of them.
Stocks similar to RIGEL PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ANIP, SEEL, and SIGA.
View All Top Stocks by Price Target
Is RIGL a Buy, Hold or Sell? See the POWR Ratings now!